Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Applied and Environmental Microbiology|December 22, 2021
Anaerobic Biodegradation of Chloroform and Dichloromethane with a Dehalobacter Enrichment CultureHao Wang, Rong Yu, Jennifer Webb, et al.
Pediatric Blood & Cancer|April 22, 2016
Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and ChelationHelen M Stanley, David F Friedman, Jennifer Webb, et al.
Environmental Science & Technology|November 14, 2023
A Multifunctional Dehalobacter? Tandem Chloroform and Dichloromethane Degradation in a Mixed Microbial CultureOlivia Bulka, Jennifer Webb, Sandra Dworatzek, et al.
Cytotherapy|January 29, 2023
Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineeringOrly R Klein, Carmem Bonfim, Allistair Abraham, et al.
BMC Medical Informatics and Decision Making|December 21, 2017
Advancing perinatal patient safety through application of safety science principles using health ITJennifer Webb, Asta Sorensen, Samantha Sommerness, et al.
Transfusion|July 12, 2021
Impact of universal irradiation on chronic transfusion for sickle cell diseaseGabriel Salinas Cisneros, Jennifer Webb, Naomi L C Luban, et al.
CNS Spectrums|July 14, 2012
Post-traumatic stress disorder symptom severity in service members returning from Iraq and Afghanistan with different types of injuriesRobert N McLay, Jennifer Webb-Murphy, Paul Hammer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 7, 2026
Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell DiseaseDiego R Hijano, Caitlin Elgarten, Elizabeth Stenge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2015
Using fludarabine to reduce exposure to alkylating agents in children with sickle cell disease receiving busulfan, cyclophosphamide, and antithymocyte globulin transplant conditioning: results of a dose de-escalation trialJohn T Horan, Ann Haight, Jacqueline Lagerlof Dioguardi, et al.
Cytotherapy|September 25, 2024
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committeeJoseph H Oved, Athena Russell, Amy DeZern, et al.
Pageof 11